New York, October 13th / PRNewswire / -- Bronstein, Gewirtz & Grossman, LLC indicate that this is a well-known investor rights law firm nationwide, which has now filed a class action against Chemours Company ( NYSE : CC ) and some of its executives.
This lawsuit is intended to represent all individuals and entities that purchased or otherwise acquired Chemours securities between February 20, 2026, and August 4, 2026 (including both start and end dates), in order to recover losses incurred due to the defendant's alleged violations of federal securities laws. The law firm encourages interested investors to visit their website bgandg.com / cases / chemours-company-cc -class_action_lawsuit to join this case.
Chemours Case Details
The indictment alleges that during the aforementioned class action, the defendant failed to disclose the following information to investors:
- The defendant made significant exaggerations regarding the after-sales support requirements for its Opteon product;
- Due to the defendant's over-selling of the Opteon product in the previous fiscal year, the demand for such products is currently declining;
- Due to these undisclosed issues, the defendant's financial guidance for the fiscal year 2026 is not reliable; and
- Therefore, the public statements made by the defendant at all relevant times are significantly false and misleading.
Chemours What should investors do next?
A class action has been filed. If you would like to view a copy of the complaint, you can visit the law firm's website at bgandg.com / cases / chemours-company-cc -class_action_lawsuit; or contact the Peretz Bronstein lawyers or client relationship managers at Bronstein , Gewirtz & Grossman , LLC , Nathan Miller, at telephone number 917-590-0911. If you have suffered losses from your investment in Chemours, you may request to be designated as the lead plaintiff by the court before December 7, 2026. Even if you are not appointed as the lead plaintiff, you will still be entitled to any recovery of funds.
Chemours Investors do not need to pay any upfront fees.
Bronstein, Gewirtz & Grossman LLC represent investors in class actions on a contingency fee basis. This means that the law firm will only request the court to reimburse its out-of-pocket expenses and attorney fees, which are usually a certain percentage of the total amount recovered, if the case is successful.
Why choose Bronstein, Gewirtz, Grossman, and LLC to act as proxies for the Chemours securities class action?
Bronstein, Gewirtz & Grossman, LLC is a nationally renowned law firm that represents investors in class actions for securities fraud and derivative lawsuits filed by shareholders. The firm claims to have recovered hundreds of millions of dollars for investors across the United States. For more information, please visit www.bgandg.com.
The founding partner of the law firm, Peretz Bronstein, stated: "The core of our business is to restore investors' capital and ensure corporate accountability, which helps to maintain the basic integrity of the market."
The law firm also invites readers to follow their updates through LinkedIn, X, Facebook, or Instagram.
Contact Information
Peretz Bronstein Lawyers or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC917-590-0911 | [ email protected ]Lawyer advertisement. Past results do not guarantee similar outcomes in the future.
